- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Apimeds Pharmaceuticals US Inc (APUS)
Track today's live Apimeds (APUS) share price, performance and key data on this page with our current NYSE:APUS stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Apimeds share price on the NYSE exchange. Use the dropdown to switch exchange for the APUS share price, head to our technical summary section, which provides analysis on Apimeds share price buy/sell indicators using real-time data (or discuss the Apimeds (APUS) stock price today with other investors in the Apimeds NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE:APUS share price (ISIN: US03771D2018) to enhance your trading decisions with our free investment tools and resources.
What Is the Apimeds Pharmaceuticals US Inc Share Price Today?
The Apimeds share price today is 2.690.
What Is the Stock Symbol for Apimeds Pharmaceuticals US Inc
The stock symbol (or 'ticker') for Apimeds Pharmaceuticals US Inc is "APUS."
What Stock Exchange Does Apimeds Pharmaceuticals US Inc Trade On?
Apimeds Pharmaceuticals US Inc is listed and trades on the NYSE stock exchange.
Is Apimeds Pharmaceuticals US Inc a Good Stock to Buy?
Determining whether Apimeds (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NYSE:APUS share price (ISIN: US03771D2018) to enhance your trading decisions with our free investment tools and resources.
What Is the Apimeds Pharmaceuticals US Inc Share Price Today?
The Apimeds share price today is 2.690.
What Is the Stock Symbol for Apimeds Pharmaceuticals US Inc
The stock symbol (or 'ticker') for Apimeds Pharmaceuticals US Inc is "APUS."
What Stock Exchange Does Apimeds Pharmaceuticals US Inc Trade On?
Apimeds Pharmaceuticals US Inc is listed and trades on the NYSE stock exchange.
Is Apimeds Pharmaceuticals US Inc a Good Stock to Buy?
Determining whether Apimeds (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.600
2.735
52 wk Range
1.510
59.700
APUS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6002.735
52 wk Range
1.51059.700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
APUS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Form 8K Apimeds Pharmaceuticals US For: 1 October- Investing.com
Form 8K Apimeds Pharmaceuticals US For: 29 September- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Earnings
Latest Release
12/11/2025
EPS / Forecast
-0.14 / --
Revenue / Forecast
-- / --
Compare APUS to Peers and Sector
Metrics to compare | APUS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPUSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.6x | −0.2x | |
PEG Ratio | 0.00 | −0.03 | 0.00 | |
Price/Book | 0.0x | 2.1x | 2.6x | |
Price / LTM Sales | 0.0x | 5.4x | 2.8x | |
Upside (Analyst Target) | - | 129.1% | 60.9% | |
Fair Value Upside | Unlock | 15.3% | 9.5% | Unlock |
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
People Also Watch
FAQ
What Is the Apimeds (NYSE: APUS) Share Price Today?
The Apimeds stock price today is 2.690 USD.
What Stock Exchange Does Apimeds (APUS) Trade On?
Apimeds is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Apimeds?
The stock symbol (also called a 'ticker') for Apimeds is "APUS."
What Is the Current Apimeds Market Capitalisation?
As of today, Apimeds (NYSE: APUS) market cap is 4.060M USD.
Is APUS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Apimeds moving averages and other technical indicators, the daily buy/sell signal for APUS stock is Strong Sell.
How Many Times Has Apimeds Stock Split?
Apimeds has split 1 times. (See the APUS stock split history page for full effective split date and price information.)
What is the current trading status of Apimeds (NYSE: APUS)?
As of 11/11/2026, Apimeds (APUS) is trading at a share price of 2.690 USD, with a previous close of 2.690 USD. The stock has fluctuated within a day range of 2.600 USD to 2.735 USD, while its 52-week range spans from 1.510 USD to 59.700 USD.
What Is the APUS Premarket Price?
APUS's last pre-market stock price is 2.760 USD. The pre-market share volume is 570.000, and the stock has decreased by 0.060, or 2.220%.
What Is the APUS After Hours Price?
APUS's last after hours stock price is 2.600 USD, the stock has decreased by -0.090, or -3.350%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.